Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 7.5B | 5.9B | 5.7B | 5.3B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 3.5B | 1.8B | 1.8B | 2.0B |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 2.6B | 2.0B | 1.9B | 1.5B |
Tax provision | 661M | 524.9M | 480.3M | 391.1M |
Net income | 1.9B | 1.5B | 1.4B | 1.1B |
Basic EPS | — | 8.7 | 8.0 | 6.5 |
Diluted EPS | — | 8.7 | 8.0 | 6.5 |
Basic average shares | — | 173.5M | 173.4M | 173.5M |
Diluted average shares | — | 173.5M | 173.4M | 173.5M |
EBITDA | — | — | — | — |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |